Lord, Abbett & Co’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-117,152
| Closed | -$6.05M | – | 667 |
|
|
2022
Q3 | $6.05M | Sell |
117,152
-63,133
| -35% | -$3.26M | 0.02% | 456 |
|
|
2022
Q2 | $4.47M | Buy |
+180,285
| New | +$4.47M | 0.02% | 504 |
|
|
2021
Q2 | – | Sell |
-565,911
| Closed | -$29M | – | 729 |
|
|
2021
Q1 | $29M | Buy |
565,911
+69,147
| +14% | +$3.54M | 0.07% | 359 |
|
|
2020
Q4 | $30.8M | Sell |
496,764
-47,632
| -9% | -$2.95M | 0.08% | 347 |
|
|
2020
Q3 | $29.8M | Buy |
544,396
+27,805
| +5% | +$1.52M | 0.1% | 304 |
|
|
2020
Q2 | $29.7M | Sell |
516,591
-168,678
| -25% | -$9.71M | 0.1% | 302 |
|
|
2020
Q1 | $27.5M | Buy |
685,269
+204,316
| +42% | +$8.21M | 0.12% | 262 |
|
|
2019
Q4 | $19M | Buy |
+480,953
| New | +$19M | 0.06% | 398 |
|